• Antonio L Aguilar-Shea, Mar Vera-García, and Robert Güerri-Fernández.
• Centro de Salud Puerta de Madrid, Atención Primaria de Madrid, Spain; Hospital Clinical Multiprofesional COVID19 Unit, Avda del Ejército 61, 28802 Alcalá de Henares (Madrid), Spain. Electronic address: antonio.aguilar@salud.madrid.org.
• Aten Primaria. 2021 Nov 1; 53 (9): 102127102127.

AbstractThe rapid identificationand isolation of COVID-19 patients has become the cornerstone for the control of the recent outbreak. Real-time quantitative polymerase chain reaction is routinely used to confirm COVID-19 diagnosis and is considered the gold standard due to high sensitivity and specificity. Nevertheless, it usually takes several days and a relatively higher cost. Antigen tests based have emerged to cope with such disadvantages, by offering rapid results, an easy-to-use procedure, and low costs. The objective of the narrative review was to provide up-to-date data about CE-marked rapid antigen tests (RATs) for COVID-19. Given their large number, the study only focused on representative and widely used in Spain (Standard Q, Nadal, Panbio, CerTest, and Wondfo). RATs have become a very useful and validated tool for controlling the spread of COVID-19 allowing the rapid identification of active infection and isolation of positive patients. The present revision of the literature has demonstrated that sensitivity and specificity of all available RATs in Spain are high and accomplish European regulations and WHO recommendations.Copyright © 2021 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.

15 keywords...

hide…